IL-33 enhances macrophage M2 polarization and protects mice from CVB3-induced viral myocarditis

• Published in: Journal of molecular and cellular cardiology Vol. 103; pp. 22 - 30
• Main Authors: Wang, Chao, Dong, Chunsheng, Xiong, Sidong
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.02.2017
• Subjects: Adoptive Transfer; Animals; Biomarkers; Cardiovascular; Coxsackievirus; Coxsackievirus Infections - diagnosis; Coxsackievirus Infections - metabolism; Coxsackievirus Infections - virology; Cytokines - metabolism; Disease Models, Animal; Disease Susceptibility; Echocardiography; Enterovirus B, Human; IL-33; Inflammation Mediators - metabolism; Interleukin-33 - metabolism; Macrophage polarization; Macrophages - immunology; Macrophages - metabolism; Male; Mice; Myocarditis - diagnosis; Myocarditis - etiology; Myocarditis - metabolism; Phenotype; Viral myocarditis; Coxsackievirus; Macrophage polarization; IL-33; Viral myocarditis
• ISSN: 0022-2828; 1095-8584; 1095-8584
• DOI: 10.1016/j.yjmcc.2016.12.010

Viral myocarditis is the inflammation caused by myocardial virus infection, and the coxsackievirus group B3 virus (CVB3) is the most common pathogen. An efficient therapeutic agent against viral myocarditis is currently unavailable. IL-33, a new member of the IL-1 cytokine superfamily, exhibits potential immunotherapeutic effect against inflammatory and autoimmune diseases. However, the functional role of IL-33 in viral myocarditis has not been investigated. To examine the therapeutic role of IL-33 in viral myocarditis, an IL-33 overexpression plasmid (pDisplay-IL-33) and IL-33 knockdown plasmid (pLL3.7-IL-33) were packaged with polyethylenimine and delivered intravenously at the orbital area of BALB/c male mice after CVB3 infection. Then, myocarditis severity was assessed 7days after infection. Results showed that IL-33 up-regulation significantly alleviated the severity of viral myocarditis with an increased cardiac contractive function and survival rate. Mechanistic studies demonstrated that IL-33 can stimulate ST2L+F4/80+ macrophages and ST2L+CD4+T cells in cardiac tissue to express IL-4, which is a potent inducer for macrophage M2 polarization. Mice with adoptive transfer of M2 macrophages exhibited less cardiac inflammation and attenuated myocarditis, suggesting the protective role of M2 macrophage in viral myocarditis. Additionally, IL-4 neutralization abolished the IL-33-mediated cardiac functional improvement in myocarditis mice. Collectively, our findings provide a novel therapeutic role for IL-33 in CVB3-induced myocarditis. •IL-33 up-regulation ameliorates CVB3-induced viral myocarditis.•IL-33 down-regulation aggravates CVB3-induced viral myocarditis.•IL-33 stimulates the ST2+ macrophages and CD4+ T cells IL-4 expression.•IL-33 can enhance macrophage M2 polarization through IL-4.